Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Tecan and JPT Peptide Technologies Announce Cooperation Agreement

Published: Thursday, October 04, 2012
Last Updated: Thursday, October 04, 2012
Bookmark and Share
Combining JPT peptide microarrays with Tecan HS 4800™ Pro and HS 400™ Pro hybridization stations for automated microarray processing.

Tecan and JPT Peptide Technologies GmbH have announced a collaborative agreement between the two specialist companies.

Within the scope of the agreement, the parties agree to co-promote JPT’s wide range of catalog peptide arrays and profiling capabilities alongside TECAN’s portfolio of leading microarray handling devices.

“We are very glad to have reached an agreement with JPT which presents enormous advantages for both companies, and also for our customers,” stated Siegfried Sasshofer, Director of Marketing Detection at TECAN Austria GmbH.

Sasshofer continued, “Providing a high level of data quality and consistency is a burning need in microarray research. JPT is clearly the market leader in the growing field of peptide microarrays and their use for seromarker discovery, immune monitoring and enzyme profiling. Combining JPT peptide microarrays with our Tecan HS 4800™ Pro and HS 400™ Pro hybridization stations for automated microarray processing will provide our customers with a new level of process standardization to maximize the value of their research.”

“Over the past decade Tecan’s instruments have been critical for JPT to develop our PepStar™ peptide array technology into a robust and reliable platform. As a consequence, it is a pleasure to team up with Tecan and to fully reap the benefits of JPT’s peptide arrays with Tecan’s devices for serological and enzymatic assays,” said Holger Wenschuh, CEO of JPT.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Tecan and TAP Biosystems Announces a Co-Marketing Agreement
Companies to automate RAFT™ 3D cell culturing on the Freedom EVO®.
Thursday, November 01, 2012
Tecan and Siloam Biosciences Co-market New ELISA System
The system is based on Tecan’s Freedom EVO® liquid handling technology and the Siloam Biosciences’ OptiMax™ microplate.
Wednesday, September 12, 2012
Tecan Award 2011 Winner Announced
Svenja Kristina Holle from UHM has won 2011 award.
Friday, February 24, 2012
Tecan and Artel Partner to Offer QC Kit
QC Kit - a fully integrated performance verification solution for Freedom EVO® workstations.
Tuesday, February 07, 2012
Tecan Launches new Services for Australasia
New business venture aimed at providing regional support to Tecan customers throughout in Australia, New Zealand and the Pacific islands.
Friday, March 12, 2010
Scientific News
Genetic Defences of Bacteria Don’t Aid Antibiotic Resistance
Genetic responses to the stresses caused by antibiotics don’t help bacteria to evolve a resistance to the medications, according to a new study by Oxford University researchers.
Detecting HIV Diagnostic Antibodies with DNA Nanomachines
New research may revolutionize the slow, cumbersome and expensive process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV.
Snapshot Turns T Cell Immunology on its Head
New research may have implications for 1 diabetes sufferers.
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
Developing a Gel that Mimics Human Breast for Cancer Research
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
New Approach to Treating Heparin-induced Blood Disorder
A potential treatment for a serious clotting condition that can strike patients who receive heparin to treat or prevent blood clots may lie within reach by elucidating the structure of the protein complex at its root.
Horse Illness Shares Signs of Human Disease
Horses with a rare nerve condition have similar signs of disease as people with conditions such as Alzheimer’s, a study has found.
How a Molecular Motor Untangles Protein
Diseases such as Alzheimer’s, Parkinson’s and prion diseases, all involve “tangled” proteins.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos